Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag Extension Study in Chronic ITP
NCT00828750Phase 3Completed
- Sponsor
- GSK
- Start
- May 2008
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eltrombopag in immune thrombocytopenia (ITP), sponsored by GSK. Started May 2008; status: completed.
02
Drugs
eltrombopag
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT00828750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00828750.